Back to today’s briefing

Story perspectives

South Korean Drug Xafty Shows Promise Against COVID-19

8/5/2025

45 9

Summary

Story summary

South Korean scientists have validated the promising oral antiviral treatment CP-COV03, known as Xafty, through a clinical trial involving 300 patients. Developed by Hyundai Bioscience, this innovative drug not only significantly alleviated COVID-19 symptoms but also lowered hospitalization risks. With potential applications for other diseases, Xafty is set to hit the market next year.

1 of 1

Story summary

South Korean scientists have validated the promising oral antiviral treatment CP-COV03, known as Xafty, through a clinical trial involving 300 patients. Developed by Hyundai Bioscience, this innovative drug not only significantly alleviated COVID-19 symptoms but also lowered hospitalization risks. With potential applications for other diseases, Xafty is set to hit the market next year.